Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024

HRTX 10.29.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-12
Name of Upcoming Event:conference call and live webcast
Full Press ReleaseSEC FilingsOur HRTX Tweets

About Gravity Analytica

Recent News

  • 12.23.2024 - Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
  • 12.03.2024 - U.S. District Court Upholds Validity of CINVANTI® Patents
  • 11.12.2024 - Heron Therapeutics Q3 2024 Conference Call

Recent Filings

  • 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 12.23.2024 - 8-K Current report
  • 12.23.2024 - EX-99.1 EX-99.1

SAN DIEGO,Oct. 29, 2024/PRNewswire/ --Heron Therapeutics, Inc.(Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast onTuesday, November 12, 2024, at8:00 a.m. ETto report third quarter 2024 financial results and discuss recent business highlights.

The conference call can be accessed by phone by utilizing the followingregistration linkwhich will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron's website atwww.herontx.com. An archive of the teleconference and webcast will also be made available on Heron's website for 60 days following the call.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visitwww.herontx.com.

Forward-looking Statements

This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.

Investor Relations and Media Contact:

Ira DuarteExecutive Vice President, Chief Financial OfficerHeron Therapeutics, Inc.iduarte@herontx.com858-251-4400

(PRNewsfoto/Heron Therapeutics, Inc.)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-third-quarter-2024-financial-results-on-tuesday-november-12-2024-302290555.html

SOURCEHeron Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com